TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/17 17:28 | 11/20/17 | ASNS | Arsanis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ross Michael Jay | MA | DT | P.d | 5,000 | 10.00 | 0 | 500 | 37 | 1,869 | I | |||||||||||||||
5/22/17 16:10 | 5/18/17 | OPHT | Ophthotech Corp. | DE | Health | Drug | Pharmaceutical Preparations | Ross Michael Jay | MA | D | M.d | 0 | 0.00 | 0 | 2 | 100 | 4 | D | |||||||||||||||
6/3/16 16:17 | 6/1/16 | OPHT | Ophthotech Corp. | DE | Health | Drug | Pharmaceutical Preparations | Ross Michael Jay | MA | D | M.d | 0 | 0.00 | 22 | 2 | New | 2 | D | 40 | 20 | -8 | 29 | 19 | 32 | 16 | 14 | 3 | -1 | -7 | -7 | -45 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |